Skip to main content
Patient journey

This page contains health-related information for reference only. It is not medical advice. Read full disclaimer

weight loss

Mini Gastric Bypass

Gastric bypass surgery refers to a technique in which the stomach is divided into a small upper pouch and a much larger lower "remnant" pouch, where the small intestine is rearranged to connect to both. Surgeons have developed several different ways to reconnect the intestine, thus leading to several different gastric bypass procedures (GBP).

Quick Facts

Recovery
Varies
Sessions
Varies
Category
weight loss
Anaesthesia
Varies
Min. stay abroad
Varies
Average Recovery
Varies
Typical Sessions
Varies
Category
weight loss

Overview

Mini gastric bypass is one of the gastric bypass procedures. Gastric bypass surgery refers to a technique in which the stomach is divided into a small upper pouch and a much larger lower 'remnant' pouch, with the small intestine rearranged to connect to both; surgeons have developed several different ways to reconnect the intestine, leading to several different gastric bypass procedures. Any gastric bypass produces a marked reduction in the functional volume of the stomach, together with an altered physiological and physical response to food, and this underlies the weight loss that follows. As with all major abdominal surgery, complications can occur.

A 2019 International Journal of Surgery paper by the originators of the mini gastric bypass reported: "The MGB consists of a long conduit from below the crow's foot extending up to the left of the angle of His." "MGB has a wide gastro-jejunal anastomosis to an anti-colic loop of jejunum 150-200 cm distal to the ligament of Trietz." It also stated: "Notably this is neither a "Single Anastomosis bypass", nor an "Omega Loop Bypass" and also not the "One Anastomosis Bypass of Carbajo"." "It is a particular technique first created by Rutledge in 1997"

A 2018 Obesity Surgery systematic review of one anastomosis (mini) gastric bypass reported: "This review reports cumulative results of 12,807 procedures in obese patients with a mean age of 41.18 years and BMI of 46.6 kg/m2. The overall mortality was 0.10% and the leak rate was 0.96%. The follow-up duration ranged from 6 months to 12 years. A marginal ulceration rate of 2.7% and an anaemia rate of 7.0% were reported. Approximately 2.0% of patients reported postoperative gastro-oesophageal reflux and 0.71% developed malnutrition. Excess weight loss at 6, 12, 24 and 60 months was 60.68, 72.56, 78.2 and 76.6% respectively." "Type 2 diabetes mellitus and hypertension resolved in 83.7 and 66.94% respectively."

A 2018 Der Chirurg systematic review of MGB/OAGB reported: "35 eligible studies were included reporting data on >15,000 patients." "The 30-day mortality rate ranged from 0-0.9% and severe complications needing intervention ranged from 0.8-7%, whereas perioperative morbidity ranged from 3.2-10.8%. The use of MGB/OAGB induced substantial weight loss with a total weight loss of 31-38% after 1 year and 23-32% after 5 years." It also reported: "The role of bile reflux as a possible risk factor for neoplastic lesions in the long-term remains a point of discussion." "Studies evaluating endpoints, such as end organ damage in diabetes, reduction of cardiovascular events and extending survival are missing and are available only for the Roux-en Y gastric bypass."

A 2020 Journal of Research in Medical Sciences narrative review stated: "The present paper outlines the need for and the nature of revisional surgery in the long-term following OAGB".

The 2022 ASMBS and IFSO indications guideline (Obesity Surgery 2023), which covers metabolic and bariatric surgery in general and not MGB specifically, states that metabolic and bariatric surgery (MBS) "is recommended for individuals with a body mass index (BMI) >35 kg/m2, regardless of presence, absence, or severity of co-morbidities", that "MBS should be considered for individuals with metabolic disease and BMI of 30-34.9 kg/m2", and that "BMI thresholds should be adjusted in the Asian population such that a BMI >25 kg/m2 suggests clinical obesity, and individuals with BMI >27.5 kg/m2 should be offered MBS".

Key Considerations

  • A 2018 Der Chirurg systematic review of MGB/OAGB reported: "The role of bile reflux as a possible risk factor for neoplastic lesions in the long-term remains a point of discussion."
  • A 2018 Der Chirurg systematic review of MGB/OAGB reported: "Studies evaluating endpoints, such as end organ damage in diabetes, reduction of cardiovascular events and extending survival are missing and are available only for the Roux-en Y gastric bypass."

Compare with

Credentials a clinic should hold

Specialty-board certifications and facility-level accreditations relevant to this procedure. Verify on the issuer's public register before booking — most issuers publish a searchable directory.

  • IFSO Centre of Excellence

    Issuer International Federation for the Surgery of Obesity

    Facility + surgical-team accreditation for bariatric surgery; requires minimum case volumes, multidisciplinary follow-up, and outcomes reporting.

    Verify on the issuer's register →

Authors cited in the outcome data

Attribution — the named first authors of the systematic reviews whose reported rates feed the outcome figures above. Listed for transparency, not as endorsement; the registry has not solicited review or comment from these authors.

Current clinical trials

Ongoing research studies registered on ClinicalTrials.gov whose intervention involves mini gastric bypass. This is a neutral pointer to public research — not an endorsement, not a recruitment drive, and not medical advice. Trial status changes often; confirm eligibility and current status with the study team via each record.

Showing 6 recent ongoing studies. Source: ClinicalTrials.gov — all matching trials (U.S. National Library of Medicine, public domain). Retrieved 2026-08-02.

Recovery Timeline

Average recovery for Mini Gastric Bypass is 0 days. Individual recovery varies — always follow your surgeon’s specific guidance.

  1. 01Day 0–1

    Immediate

    First 24–48 hours post-procedure. Monitoring, anaesthesia recovery, initial pain management. Most clinics expect you to remain on-site or nearby.

  2. 02Day 2–2

    Early recovery

    Wound care, swelling or bruising peaks, restricted activity. Typical window for follow-up visits and drain removal if applicable. Travel is usually not advised.

  3. 03Day 3–3

    Intermediate recovery

    Gradual return to non-strenuous daily activity. Many international patients fly home during this window. Surgeon may require medical clearance for long-haul travel.

  4. 04Day 4–0

    Full recovery

    Return to full activity, exercise, and work. Final results may still be settling. Final follow-up with local doctor recommended.

Questions to Ask Your Clinic

  1. 01How is the length of bypassed small bowel chosen, and where will the loop be joined?
  2. 02What is the surgeon's own rate of leak, marginal ulcer and revision, and over what number of cases?
  3. 03What nutritional blood tests and supplements are required after surgery, and for how long?

Browse all destinations offering Mini Gastric Bypass →

Frequently Asked Questions

What is a mini gastric bypass?

It is one of the gastric bypass procedures. In a gastric bypass the stomach is divided into a small upper pouch and a much larger lower remnant pouch, and the small intestine is rearranged to connect to both. Surgeons have developed several different ways to reconnect the intestine, which is why more than one type of gastric bypass exists.

How does gastric bypass lead to weight loss?

Any gastric bypass produces a marked reduction in the functional volume of the stomach, accompanied by an altered physiological and physical response to food. Together these changes reduce how much can be eaten and how the body handles what is eaten, resulting in weight loss.

What are the risks?

As with all major abdominal surgery, complications can occur.

What does the 2022 ASMBS and IFSO guideline say about who is considered for metabolic and bariatric surgery?

The 2022 ASMBS and IFSO indications guideline (Obesity Surgery 2023), which covers metabolic and bariatric surgery in general and not MGB specifically, states that metabolic and bariatric surgery (MBS) "is recommended for individuals with a body mass index (BMI) >35 kg/m2, regardless of presence, absence, or severity of co-morbidities", that "MBS should be considered for individuals with metabolic disease and BMI of 30-34.9 kg/m2", and that "BMI thresholds should be adjusted in the Asian population such that a BMI >25 kg/m2 suggests clinical obesity, and individuals with BMI >27.5 kg/m2 should be offered MBS".

What did systematic reviews report for weight loss and resolution of conditions after MGB/OAGB?

A 2018 Obesity Surgery systematic review of one anastomosis (mini) gastric bypass reported: "This review reports cumulative results of 12,807 procedures in obese patients with a mean age of 41.18 years and BMI of 46.6 kg/m2. The overall mortality was 0.10% and the leak rate was 0.96%. The follow-up duration ranged from 6 months to 12 years. A marginal ulceration rate of 2.7% and an anaemia rate of 7.0% were reported. Approximately 2.0% of patients reported postoperative gastro-oesophageal reflux and 0.71% developed malnutrition. Excess weight loss at 6, 12, 24 and 60 months was 60.68, 72.56, 78.2 and 76.6% respectively." "Type 2 diabetes mellitus and hypertension resolved in 83.7 and 66.94% respectively." A 2018 Der Chirurg systematic review of MGB/OAGB reported: "The 30-day mortality rate ranged from 0-0.9% and severe complications needing intervention ranged from 0.8-7%, whereas perioperative morbidity ranged from 3.2-10.8%. The use of MGB/OAGB induced substantial weight loss with a total weight loss of 31-38% after 1 year and 23-32% after 5 years."

What complications have been reported after MGB/OAGB?

A 2018 Obesity Surgery systematic review of one anastomosis (mini) gastric bypass reported: "The overall mortality was 0.10% and the leak rate was 0.96%." "A marginal ulceration rate of 2.7% and an anaemia rate of 7.0% were reported. Approximately 2.0% of patients reported postoperative gastro-oesophageal reflux and 0.71% developed malnutrition." A 2018 Der Chirurg systematic review of MGB/OAGB reported: "The 30-day mortality rate ranged from 0-0.9% and severe complications needing intervention ranged from 0.8-7%, whereas perioperative morbidity ranged from 3.2-10.8%. The use of MGB/OAGB induced substantial weight loss with a total weight loss of 31-38% after 1 year and 23-32% after 5 years."

Are there long-term concerns about mini gastric bypass?

A 2018 Der Chirurg systematic review of MGB/OAGB reported: "The role of bile reflux as a possible risk factor for neoplastic lesions in the long-term remains a point of discussion." "Studies evaluating endpoints, such as end organ damage in diabetes, reduction of cardiovascular events and extending survival are missing and are available only for the Roux-en Y gastric bypass."

Parent procedure

Mini Gastric Bypass is a variant of Roux-en-Y Gastric Bypass. See the parent procedure for the broader category context.

Conditions treated

Clinical conditions for which mini gastric bypass is a treatment-ladder option.

Related Procedures

Other weight loss procedures in our registry

Related tools